Lyme-disease vaccine is 76% to 92% effective

Article Abstract:

Research reports from SmithKline Beechman PLC and Rhone-Poulenc SA show that the Lyme-disease vaccine is 76% to 92% effective in protecting adults against Lyme-disease infection. The studies involve two different versions of essentially the same vaccine. Both work by triggering the body's immune system to generate anti-bodies that can destroy the tick-borne bacterium which causes the disease. The studies don't prove the vaccines can prevent infection among children. The vaccine may be available in early 1999.

Comment:

Lyme-disease vaccine is 76% to 92% effective.

Product development, Drugs & Pharmaceuticals, Pharmaceutical and Medicine Manufacturing, France, Company Planning/Goals, Drugs, SmithKline Beecham PLC, Rhone-Poulenc S.A.

---

Lehman wins decision to freeze foreign assets of big Russian bank

Article Abstract:

SBS-Agro's overseas assets have been frozen in some parts of Europe as a result of Lehman Brothers Holdings Inc.'s legal action. The London division of Lehman Brothers implemented legal action against SBS-Agro after it did not comply with its financial obligations to the investment bank. A London court approved Lehman's request to freeze $113 million of Uneximbank and Inkombank's assets in the UK.

Comment:

SBS-Agro's overseas assets frozen in some parts of Europe as a result of Lehman Brothers Holdings Inc.'s legal action

Commercial Banks, Commercial Banking, Legal issues & crime, Investment Banking and Securities Dealing, Investment Banking, Legal/Government Regulation, Investment banks, Lehman Brothers Holdings Inc., SBS-AGRO

---

Similar abstracts:

• Abstracts: Gore to unveil savings bonds with rates tied to inflation. Foreign banks pulled out of Asia late, a report says
• Abstracts: Pressure mounts to oust chief of New York utility. "Star Trek" series to become video games
• Abstracts: America West airline fined $2.5 million for violations. Kiwi bankruptcy sets stage for link with Pan Am. Counterfeiters competing for golf equipment market
• Abstracts: FDA is putting the squeeze on makers of fresh juice Founders deny dual records at Livent Inc
• Abstracts: Ashland will record $57 million in charges for fiscal 4th period

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.